Novartis is set to launch its one-off gene therapy Zolgensma for the ultra-rare muscle-wasting disease spinal muscular atrophy (SMA) in Germany at the start of July priced at 1,945,000 eu ...

Problems with chemical messengers like dopamine were tied to posture issues in SMA in a mouse study, but levodopa therapy may ease symptoms.

FuelCell Energy FCEL is trading below its 50-day and 200-day simple moving average (SMA), signaling a bearish trend. FCEL ...

In case EUR/USD drops below 1.0380-1.0390 (200-period SMA on the 4-hour chart, Fibonacci 50% retracement of the latest ...

The company argues that SMA costs per child range from 2.5 million ... framework” and is reimbursement expected to begin in Germany shortly. European approval is based on the completed phase ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

German lawmakers have approved weapons and equipment orders worth about 2.5 billion euros ($2.6 billion) for the armed forces ...

The ECB (European Central Bank) continued policy normalisation today, with another 25 basis points (bps) worth of cuts across ...

His comments to the hard-right Alternative for Germany party escalated efforts by the billionaire to influence the country’s election for chancellor next month. By Jim Tankersley and Christopher F.